RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All Interventional Pain Management Articles

Percutaneous electrical neurostimulation can accomplish a safe, cost-effective, and rapid reduction in the use of opioids, even when previous weaning methods have been unsuccessful.
Combined electrochemical treatment uses local anesthetic blocks in conjunction with electric cell signaling treatment (EST) to successfully treat neuropathies of all causes. Learn more about this innovative treatment technique.
Cranial Electrotherapy Stimulation (CES) has the potential to improve pain and headache outcomes. Learn how to incorporate this techniques, either as an adjunct to traditional treatment or as a stand-alone option, for the management of pain and headache.
Learn more about the role of neurostimulators, specifically spinal cord stimulators, in pain management.
Selective spinal and joint injections are being performed with increasing frequency in the management of acute and chronic disorders of the musculoskeletal system. Effective treatment of chronic spine and joint pain requires accurate identification of the correct pain source.
Transcranial direct current stimulation (tDCS) is a non-invasive, painless brain stimulation technique that is showing promise in the treatment of depression and chronic pain.1 tDCS is delivered through a battery-operated device that transfers electrical current of low intensity (1-2 mA) to the surface of the head, typically with 2 large (20-35 cm2) saline-soaked sponge-el
After a reader's brother went blind following a epidural steroid injection, our Editorial Board examines the safety of epidural steroid injections.
There are several evidence-based (EB) guidelines that address the use of epidural injections for the treatment of low back pain. But how influential are these guidelines to the everyday decision-making of physicians?
While the frequency of serious complications due to ESI is undefined, certain pharmaceutical characteristics of corticosteroids (ie, particulate vs nonparticulate) are thought to contribute to overall risk.
Spinal cord stimulation should no longer be considered the treatment of “last resort.” Long-term success rates reach 85% if SCS is performed within 2 years of symptom onset.
Despite improved understanding of pain mechanisms, interpretation of pain signals, and development of new analgesic techniques, the under-treatment of postoperative pain continues.
Opioid intrathecal therapy offers the advantage of delivering medication directly to the dorsal horn of the spinal cord—increasing potency and reducing the systemic exposure—thus reducing side effects.
For patients with chronic migraine, botulinum neurotoxin injections have helped reduce the frequency, duration, and disability of headaches.
Interventional pain specialists offer an overview of spinal cord stimulation (dorsal column neuromodulation) fundamentals that referring physicians can use in clinical practice.
close X
SHOW MAIN MENU
SHOW SUB MENU